Sharenet Sites 
Sharenet Sites
Special Dividend and changes to the Board, the Board Charter, and terms of the Nominations and Governance Committee
LIFE HEALTHCARE GROUP HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
(Registration number: 2003/002733/06)
ISIN: ZAE000145892
JSE and A2X share code: LHC
("Life Healthcare" or the "Company" or "the Group")
LIFE HEALTHCARE FUNDING LIMITED
(Incorporated in the Republic of South Africa with limited liability)
Registration number: 2016/273566/06
LEI: 3789SJPQJZF8ZYXTZ394
Bond company code: LHFI
("Life Healthcare Funding")
DECLARATION OF A SPECIAL DIVIDEND AND CHANGES TO THE BOARD, THE BOARD
CHARTER, AND TERMS OF THE NOMINATIONS AND GOVERNANCE COMMITTEE
Declaration of Special Dividend
The Board of directors of Life Healthcare ("Board") is pleased to announce the approval and declaration
of a gross special cash dividend of 235.00 cents per ordinary share ("Special Dividend"). This Special
Dividend, payable from income reserves, is the distribution of the net proceeds received following the
disposal of the Group's interest in Life Molecular Imaging (the "Transaction") which has unlocked
significant value for Life Healthcare shareholders ("Shareholders").
This Special Dividend is subject to approval by the South African Reserve Bank ("SARB") before it can
be paid ("the Condition"). A further announcement will be released once the Condition has been fulfilled.
The Special Dividend will be subject to South African dividend withholding tax at a rate of 20%. This will
result in a net dividend of 188.00 cents per ordinary share for those Shareholders who are subject to
dividend withholding tax or who are not subject to a reduced rate in terms of any applicable agreement
for the avoidance of double taxation between South Africa and such Shareholders' country of residence.
The Company's total number of issued ordinary shares is 1 467 349 162 as at the date of declaration
of the Special Dividend. The Company's income tax reference number is 9387/307/15/1.
Shareholders' attention is drawn to the following preliminary indicative salient dates regarding the
Special Dividend – assuming timely approval by SARB is received by 9 September 2025:
Finalisation date Tuesday, 9 September 2025
(announcement to be released on SENS by 11:00)
Last day to trade to participate in the Special Dividend Tuesday, 16 September 2025
Shares commence trading ex-dividend on Wednesday, 17 September 2025
Record date Friday, 19 September 2025
Special Dividend payment date Monday, 22 September 2025
Share certificates may not be dematerialised or re-materialised between Wednesday 17 September
2025 and Friday, 19 September 2025, both days inclusive.
The salient dates above are on the basis that the Condition will be fulfilled by Tuesday, 9 September
2025. To the extent that the Condition is not fulfilled by Tuesday, 9 September 2025, a further
announcement will be released by the Company to inform Shareholders thereof and to provide an
updated timetable in respect of the Special Dividend.
For further information, please contact: investor.relations@lifehealthcare.co.za
Changes to the board of directors
Shareholders and noteholders are advised that, in line with board succession plans, Professor Marian
Jacobs and Dr Jeanne Bolger will retire down from the Board at the Company's 2026 Annual General
Meeting ("2026 AGM") in February next year. At that point Professor Jacobs will step down as Chairman
of the Clinical Committee as well as a member of the Social, Ethics and Transformation Committee and
Dr Bolger will step down as a member of the Clinical and Investment Committees. Dr Fareed Abdullah
will assume the position of Chairman of the Clinical Committee at that time.
In addition, Professor Raymond Campbell will join the Investment Committee and Dr Abdullah will join
the Social, Ethics and Transformation Committee with effect from 1 October 2025.
Changes to the Board Charter
In accordance with the annual review of the Company's governance documents, shareholders and
noteholders are advised that amendments have been made to the Company's Board Charter. A copy
of the updated Board Charter is available through a secure electronic manner at the election of the
person requesting inspection and can be found at https://www.lifehealthcare.co.za/media/3978/8-
board-charter-2024-final.pdf
Changes to the Terms of Reference of the Nominations and Governance Committee
Shareholders and noteholders are also advised that the terms of reference of the Nominations and
Governance Committee ("the Terms of Reference") has been updated. The updated Terms of Reference
is available through a secure electronic manner at the election of the person requesting inspection and
can be found at https://www.lifehealthcare.co.za/media/3979/7-nomgov-tor-2024-final.pdf
Dunkeld
7 August 2025
Equity Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)
Debt Sponsor
QUESTCO CORPORATE ADVISORY
Date: 07-08-2025 08:05:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
